Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | SMMT |
---|---|---|
09:32 ET | 308140 | 20.71 |
09:34 ET | 256710 | 20.1532 |
09:36 ET | 365417 | 20.0101 |
09:38 ET | 130031 | 20.36 |
09:39 ET | 115746 | 20.3901 |
09:41 ET | 98043 | 20.7155 |
09:43 ET | 92151 | 20.95 |
09:45 ET | 110348 | 21.1 |
09:48 ET | 65030 | 20.89 |
09:50 ET | 47787 | 21.23 |
09:52 ET | 74549 | 20.925 |
09:54 ET | 64133 | 20.65 |
09:56 ET | 36224 | 20.77 |
09:57 ET | 83940 | 20.5503 |
09:59 ET | 29681 | 20.77 |
10:01 ET | 56294 | 21.1926 |
10:03 ET | 46522 | 21.3309 |
10:06 ET | 23974 | 21.405 |
10:08 ET | 20000 | 21.2 |
10:10 ET | 63868 | 21.45 |
10:12 ET | 24290 | 21.42 |
10:14 ET | 26221 | 21.325 |
10:15 ET | 34798 | 21.28 |
10:17 ET | 17232 | 21.2 |
10:19 ET | 23922 | 21.26 |
10:21 ET | 24641 | 21.27 |
10:24 ET | 33343 | 21.2583 |
10:26 ET | 21981 | 21.3 |
10:28 ET | 19509 | 21.25 |
10:30 ET | 49767 | 21.0401 |
10:32 ET | 29314 | 21.205 |
10:33 ET | 10085 | 21.27 |
10:35 ET | 8240 | 21.305 |
10:37 ET | 28320 | 21.2992 |
10:39 ET | 38943 | 21.3 |
10:42 ET | 39878 | 21.255 |
10:44 ET | 13270 | 21.083 |
10:46 ET | 29362 | 21.01 |
10:48 ET | 11464 | 21.0401 |
10:50 ET | 22217 | 21.19 |
10:51 ET | 8857 | 21.22 |
10:53 ET | 7743 | 21.2699 |
10:55 ET | 4215 | 21.24 |
10:57 ET | 9043 | 21.205 |
11:00 ET | 21857 | 21.2 |
11:02 ET | 11289 | 21.155 |
11:04 ET | 13033 | 21.255 |
11:06 ET | 8258 | 21.22 |
11:08 ET | 19053 | 21.26 |
11:09 ET | 19754 | 21.3679 |
11:11 ET | 13058 | 21.2 |
11:13 ET | 6740 | 21.25 |
11:15 ET | 2120 | 21.2162 |
11:18 ET | 11566 | 21.08 |
11:20 ET | 7978 | 21.07 |
11:22 ET | 42495 | 21.1 |
11:24 ET | 6305 | 21.11 |
11:26 ET | 5053 | 21.1099 |
11:27 ET | 5568 | 21.0301 |
11:29 ET | 15854 | 21.02 |
11:31 ET | 12897 | 21.1421 |
11:33 ET | 10973 | 21.26 |
11:36 ET | 22523 | 21.287 |
11:38 ET | 3498 | 21.21 |
11:40 ET | 4200 | 21.1901 |
11:42 ET | 1015 | 21.21 |
11:44 ET | 3335 | 21.29 |
11:45 ET | 11035 | 21.31 |
11:47 ET | 2428 | 21.2915 |
11:49 ET | 3756 | 21.3011 |
11:51 ET | 7169 | 21.17 |
11:54 ET | 4376 | 21.22 |
11:56 ET | 3246 | 21.21 |
11:58 ET | 4095 | 21.228 |
12:00 ET | 5111 | 21.2 |
12:02 ET | 8666 | 21.18 |
12:03 ET | 4989 | 21.235 |
12:05 ET | 29320 | 21.06 |
12:07 ET | 4564 | 21.14 |
12:09 ET | 2023 | 21.145 |
12:12 ET | 7963 | 21.12 |
12:14 ET | 8090 | 21.07 |
12:16 ET | 12368 | 21.07 |
12:18 ET | 13708 | 21.09 |
12:20 ET | 7293 | 21.08 |
12:21 ET | 10299 | 21.11 |
12:23 ET | 15992 | 21.07 |
12:25 ET | 6610 | 21.062 |
12:27 ET | 4984 | 21.06 |
12:30 ET | 3675 | 21.06 |
12:32 ET | 62420 | 21.0003 |
12:34 ET | 27247 | 20.8017 |
12:36 ET | 30330 | 20.59 |
12:38 ET | 39452 | 20.6675 |
12:39 ET | 9057 | 20.75 |
12:41 ET | 11005 | 20.69 |
12:43 ET | 11441 | 20.6804 |
12:45 ET | 10521 | 20.61 |
12:48 ET | 11747 | 20.6301 |
12:50 ET | 11451 | 20.726512 |
12:52 ET | 23158 | 20.78 |
12:54 ET | 33818 | 20.71 |
12:56 ET | 16017 | 20.7 |
12:57 ET | 5950 | 20.7 |
12:59 ET | 9718 | 20.6501 |
01:01 ET | 10656 | 20.75 |
01:03 ET | 15694 | 20.655 |
01:06 ET | 9772 | 20.71 |
01:08 ET | 12861 | 20.62 |
01:10 ET | 8501 | 20.575 |
01:12 ET | 7527 | 20.62 |
01:14 ET | 1981 | 20.6324 |
01:15 ET | 9611 | 20.66 |
01:17 ET | 10431 | 20.775 |
01:19 ET | 6798 | 20.665 |
01:21 ET | 7079 | 20.655 |
01:24 ET | 4122 | 20.68 |
01:26 ET | 5461 | 20.705 |
01:28 ET | 7394 | 20.73 |
01:30 ET | 9684 | 20.712 |
01:32 ET | 11222 | 20.73 |
01:33 ET | 5418 | 20.71 |
01:35 ET | 4100 | 20.73 |
01:37 ET | 13822 | 20.68 |
01:39 ET | 11107 | 20.63 |
01:42 ET | 10882 | 20.64 |
01:44 ET | 12906 | 20.62 |
01:46 ET | 7676 | 20.7 |
01:48 ET | 15204 | 20.72 |
01:50 ET | 13978 | 20.7194 |
01:51 ET | 15821 | 20.79 |
01:53 ET | 31749 | 20.99 |
01:55 ET | 25112 | 21.02 |
01:57 ET | 12237 | 20.86 |
02:00 ET | 7761 | 20.83 |
02:02 ET | 11269 | 20.7807 |
02:04 ET | 7633 | 20.745 |
02:06 ET | 5064 | 20.75 |
02:08 ET | 5501 | 20.78 |
02:09 ET | 4242 | 20.84 |
02:11 ET | 6558 | 20.825 |
02:13 ET | 2249 | 20.86 |
02:15 ET | 4866 | 20.89 |
02:18 ET | 3495 | 20.9043 |
02:20 ET | 6720 | 20.9233 |
02:22 ET | 10263 | 21 |
02:24 ET | 9255 | 21.02 |
02:26 ET | 6145 | 21.0748 |
02:27 ET | 8560 | 21.0258 |
02:29 ET | 4962 | 21.02 |
02:31 ET | 7303 | 21 |
02:33 ET | 15687 | 21.16 |
02:36 ET | 17830 | 21.22 |
02:38 ET | 10023 | 21.19 |
02:40 ET | 24463 | 21.25 |
02:42 ET | 12962 | 21.33 |
02:44 ET | 17411 | 21.32 |
02:45 ET | 13395 | 21.305 |
02:47 ET | 35594 | 21.398 |
02:49 ET | 16590 | 21.44 |
02:51 ET | 18240 | 21.4601 |
02:54 ET | 14473 | 21.465 |
02:56 ET | 16264 | 21.4401 |
02:58 ET | 20881 | 21.4561 |
03:00 ET | 22255 | 21.415 |
03:02 ET | 10305 | 21.41 |
03:03 ET | 12148 | 21.455 |
03:05 ET | 16261 | 21.475 |
03:07 ET | 23574 | 21.465 |
03:09 ET | 28666 | 21.49 |
03:12 ET | 11884 | 21.47 |
03:14 ET | 29766 | 21.425 |
03:16 ET | 15615 | 21.42 |
03:18 ET | 23515 | 21.37 |
03:20 ET | 15679 | 21.29 |
03:21 ET | 11704 | 21.3 |
03:23 ET | 10737 | 21.36 |
03:25 ET | 6426 | 21.4093 |
03:27 ET | 12954 | 21.3701 |
03:30 ET | 7523 | 21.42 |
03:32 ET | 10037 | 21.41 |
03:34 ET | 8553 | 21.34 |
03:36 ET | 15698 | 21.21 |
03:38 ET | 16475 | 21.15 |
03:39 ET | 14121 | 21.176 |
03:41 ET | 9318 | 21.16 |
03:43 ET | 15879 | 21.12 |
03:45 ET | 19268 | 21.0536 |
03:48 ET | 26868 | 21.09 |
03:50 ET | 24622 | 21.05 |
03:52 ET | 39529 | 21.005 |
03:54 ET | 24717 | 21.06 |
03:56 ET | 27689 | 21.035 |
03:57 ET | 90979 | 20.9 |
03:59 ET | 270821 | 20.885 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Summit Therapeutics Inc | 22.4B | -90.9x | --- |
Vaxcyte Inc | 15.4B | -24.5x | --- |
Insmed Inc | 12.8B | -13.4x | --- |
Viking Therapeutics Inc | 7.4B | -65.7x | --- |
Legend Biotech Corp | 9.2B | -31.4x | --- |
Revolution Medicines Inc | 7.3B | -12.1x | --- |
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. It develops ivonescimab in non-small cell lung cancer (NSCLC), specifically launching Phase III clinical trials in the indications such as ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (HARMONi), and ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients (HARMONi-3). Its ivonescimab is engineered with Akeso's Tetrabody technology.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $22.4B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 702.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.99 |
EPS | $-0.23 |
Book Value | $0.11 |
P/E Ratio | -90.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.